Australian and New Zealand anaesthetic allergy group/Australian and New Zealand college of anaesthetists perioperative anaphylaxis management guidelines

Anaesthesia and Intensive Care

Volumn 45, Issue 2, 2017, Pages 151-158

  Kolawole, H ^a   Marshall, S D ^b   Crilly, H ^c   Kerridge, R ^d   Roessler, P ^e  

^a MONASH UNIVERSITY   (Australia)

^b Tweed Heads Hospital ^*  (Australia)

^c Tweed Heads Hospital   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e Australia New Zealand College of Anaesthetists   (Australia)

Author keywords

Adrenaline; Anaphylaxis; Perioperative medicine; Resuscitation

Indexed keywords

ANESTHETIC AGENT;

ANAPHYLAXIS; ANESTHESIA; ANESTHESIST; ARTICLE; AUSTRALIAN; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; HUMAN; NEW ZEALAND; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; AUSTRALIA;

ANAPHYLAXIS; ANESTHETISTS; AUSTRALIA; HUMANS; NEW ZEALAND; PERIOPERATIVE PERIOD; PRACTICE GUIDELINES AS TOPIC;

EID: 85016502273     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1704500204     Document Type: Article

References (70)

1. Safety of Anaesthesia: A review of anaesthesia-related mortality reporting in Australia and New Zealand 2009-2011. McNicol L Ed. Australian and New Zealand College of Anaesthetists, Melbourne 2014. http://www.anzca.edu.au/documents/soa-mortality-report-p4.pdf. Accessed October 2016.
2. Safety of Anaesthesia: A review of anaesthesia-related mortality reporting in Australia and New Zealand 2012-2014. McNicol L Ed. Australian and New Zealand College of Anaesthetists, Melbourne 2016. (To be published).
3. Marshall SD, Sanderson P, McIntosh C, Kolawole H. The effect of two cognitive aid designs on team functioning during intraoperative anaphylaxis emergencies: a multi-centre simulation study. Anaesthesia 2016; 71:389-404.
4. Truhlar A, Deakin CD, Soar J, Khalifa GEA, Alfonzo A, Bierens JJLM et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 4. Cardiac arrest in special circumstances. Resuscitation 2015; 95:148-201.
5. Lavonas EJ, Drennan IR, Gabrielli A, Heffner AC, Hoyte CO, Orkin AM et al. Part 10: Special Circumstances of Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015; 132:S501-S518.
6. Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. Anaphylaxis: Guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69:1026-1045.
7. Simons FE, Ardusso LR, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF et al. World Allergy Organization. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013; 162:193-204.
8. Simons FE, Ardusso LRF, Bilò MB, El-Gamal YM, Ledford DK, Ring J et al. World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. World Allergy Organ J 2011; 4:13-37.
9. Hoek TLV, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ. 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 12: Cardiac arrest in special situations. Circulation 2010; 122:S829-S861.
10. Australian Resuscitation Council and New Zealand Resuscitation Council. Guideline 11.10 Resuscitation in Special Circumstances. November 2011. https://resus.org.au/guidelines/. Accessed October 2016.
11. Mertes PM, Malinovsky JM, Jouffroy L, Aberer W, Terreehorst I, Brockow K, Demoly P. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 21:442-453.
12. Association of Anaesthetists of Great Britain and Ireland. Suspected anaphylactic reaction associated with anaesthesia. Anaesthesia 2009; 64:199-211.
13. Rose MA, Fisher MM. Anaphylaxis and anaesthesia. What can we do better? Australasian Anaesthesia 2009; 115-119.
14. Kroigaard M, Garvey LH, Gillberg L, Johansson SGO, Mosbech H, Florvaag E et al. Scandinavian clinical practice guidelines on diagnosis, management and follow up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 2007; 51:655-670.
15. Brown SGA, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust 2006; 185:283-289.
16. Australasian Society of Clinical Immunology and Allergy. Anaphylaxis: Emergency Management for Health Professionals (poster) Australian Prescriber 2011; 34: http://www. australianprescriber.com/magazine/34/4/artid/1210. Accessed October 2016.
17. Marshall S. The use of cognitive aids during emergencies in anesthesia: a review of the literature. Anesth Analg 2013; 117:1162-1171.
18. Burden AR, Carr ZJ, Staman GW, Littman JJ, Torjman MC. Does every code need a "reader?" improvement of rare event management with a cognitive aid "reader" during a simulated emergency: a pilot study. Simul Healthc 2012; 7:1-9.
19. Sheikh A, Shehata YA, Brown SGA, Simons FE. Adrenaline for the treatment of anaphylaxis with and without shock. The Cochrane Library 2008.
20. Garvey LH, Belhage B, Kroigaard M. Treatment with epinephrine (adrenaline) in suspected anaphylaxis during anaesthesia in Denmark. Anesthesiology 2011; 115:111-116.
21. Brown SGA. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allerg Clin Immuno 2005; 5:359-364.
22. Fisher MM, Ramakrishnan N, Doig G, Rose M, Baldo B. The nvestigation of bronchospasm during induction of anaesthesia. Acta Anaesthesiol Scand 2009; 53:1006-1011.
23. Mertes PM, Lambert M, Gueant-Rodriguez RM, Aimone-Gastin I, Mouton-Faivre C, Moneret-Vautrin DA et al. Perioperative anaphylaxis. Immunol Allergy Clin North Am 2009; 29:429-451.
24. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fata reaction? Curr Opin Allergy Clin Immunol 2004; 4:285-290.
25. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99:536-545.
26. Rose MA, Green SL, Crilly HM, Kolawole H. Perioperative anaphylaxis grading system: 'making the grade'. Br J Anaesth 2016; doi: 10.1093/bja/aew251.http://bja.oxfordjournals.org/cgi/reprint/aew251?ijkey=sPXCyYUW5T0m3zd&keytype=ref Accessed October 2016.
27. Campbell RL, Bellolio MF, Knutson BD, Bellamkonda VR, Fedko MG, Nestler DM, Hess EP. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with ntramuscular epinephrine. J Allergy Clin Immunol Pract 2015; 3:76-80.
28. Shaver KJ, Adams C, Weiss SJ. Acute myocardial infarction after administration of low-dose intravenous epinephrine for anaphylaxis. CJEM 2006; 8:289-294.
29. Johnston SL, Unsworth J, Gompels MM. Adrenaline given outside the context of life threatening allergic reactions. Br Med J 2003; 326:589-590.
30. Pumphrey RS. Lessons for the management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144-1150.
31. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: ntramuscular versus subcutaneous injection. J Allergy Clin mmunol 2001; 108:871-887.
32. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998; 101:33-37.
33. O'Meara M, Watton DJ. Advanced Paediatric Life Support: The Practical Approach. Appendix J Formulary. 5th [Australian] ed. 2013. Blackwell, West Sussex.
34. Brown SGA, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with ntravenous adrenaline and volume resuscitation. Emerg Med J 2004; 21:149-154.
35. Mink SN, Simons FE, Simons KJ, Becker AB, Duke K. Constant nfusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin Exp Allergy 2004; 34:1776-1783.
36. Shann F. Drug Doses. 16th Edition 2014. Royal Children's Hospital, Melbourne.
37. Clarke R, Sadleir PHM, Van Niekerk AW, Platt P. Quantification of volume loss and haemodynamic changes of Gelofusine®-induced anaphylaxis during cardiopulmonary bypass. Anaesth Intensive Care 2011; 39:492-495.
38. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth ntensive Care 1986; 14:17-21.
39. Tajima K, Zheng F, Collange O, Barthel G, Thornton SN, Longrois D et al. Time to achieve target mean arterial pressure during resuscitation from experimental anaphylactic shock in an anima model. A comparison of adrenaline alone or in combination with different volume expanders. Anaesth Intensive Care 2013; 41:765-773.
40. Pumphrey RSH. Fatal posture in anaphylactic shock. J Allergy Clin mmunol 2003; 112:451-452.
41. Reddy JI, Cooke PJ, van Schalkwyk JM, Hannam J A, Fitzharris P, Mitchell SJ. Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology 2015; 122:39-45.
42. Gibbs NM, Sadleir PH, Clarke RC, Platt PR. Survival from perioperative anaphylaxis in Western Australia 2000-2009. Br J Anaesth 2013; 111:589-593.
43. Sadleir PH, Clarke RC, Bunning DL, Platt PR. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002-2011. Br J Anaesth 2013; 110:981-987.
44. Brereton A, Russell WJ. Anaphylaxis to muscle relaxants: an audit of ten years of allergy testing at the Royal Adelaide Hospital. Anaesth Intensive Care 2012; 40:861-866.
45. McNeill O, Kerridge RK, Boyle MJ. Review of procedures for nvestigation of anaesthesia-associated anaphylaxis in Newcastle, Australia. Anaesth Intensive Care 2008; 36:201-207.
46. Sharp G, Green S, Rose M. Chlorhexidine-induced anaphylaxis in surgical patients: a review of the literature. ANZ J Surg 2016; 86:237-243.
47. Jee R, Nel L, Gnanakumaran G, Williams A, Eren E. Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg? Br J Anaesth 2009; 103:614-615.
48. ANZCA Professional Documents. PS60 Guidelines on the perioperative management of patients with suspected or proven hypersensitivity to chlorhexidine, 2015. From: http://www. anzca.edu.au/resources/professional-documents/pdfs/ps60-2015-guidelines-on-the-perioperative-management-of-patients-with-suspected-or-proven-hypersensitivity-to-chlorhexidine.pdf Accessed October 2016.
49. The Australian and New Zealand Committee on Resuscitation. Guideline 11.2 Protocols for Adult Advanced Life Support. January 2016. https://resus.org.au/guidelines/. Accessed October 2016.
50. ANZCA Professional Standards. PS18 Recommendations on Monitoring during Anaesthesia, 2008. From: http://www.anzca. edu.au/resources/professional-documents/pdfs/ps18-2013-recommendations-on-monitoring-during-anaesthesia.pdf Accessed October 2016.
51. Tan CO, Brace G, Weinberg L, Howard W Successful resuscitation of class 4 anaphylaxis guided by transthoracic echocardiography. Anaesth Intensive Care 2014; 42:144-145.
52. Schummer C, Wirsing M, Schummer W The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008; 107:620-624.
53. Meng L Treatment of rocuronium-induced anaphylactic shock with vasopressin. Can J Anaesth 2008; 55:437-440.
54. Dewachter P, Raeth-Fries I, Jouan-Hureaux V, Menu P, Vigneron C, Longrois D et al. A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock. Anesthesiology 2007; 106:977-983.
55. Green R, Ball A. Alpha-agonists for the treatment of anaphylactic shock. Anaesthesia 2005; 60:621-622.
56. Heytman M, Rainbird A. Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review. Anaesthesia 2004; 59:1210-1215.
57. Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 2004; 134:260-261.
58. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005; 22:272-273.
59. Lampin ME, Rousseaux J, Botte A, Sadik A, Cremer R, Leclerc F. Noradrenaline use for septic shock in children: doses, routes of administration and complications. Acta Paediatrica 2012; 101:426-430.
60. Carroll TG, Dimas VV, Raymond TT. Vasopressin rescue for in-pediatric intensive care unit cardiopulmonary arrest refractory to initial epinephrine dosing: a prospective feasibility pilot trial. Pediatr Crit Care Med 2012; 13:265-272.
61. Di Chiara L, Stazi GV, Ricci Z, Polito A, Morelli S, Giorni C et al. Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report. J Med Case Rep 2008; 2:36.
62. Weiss GM, Fandrick AD, Sidebotham D. Successful rescue of an adult with refractory anaphylactic shock and abdominal compartment syndrome with venoarterial extracorporeal membrane oxygenation and bedside laparotomy. Semin Cardiothor Vasc Anesthesia 2015; 19:66-70.
63. Simons FER, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012; 130:597-605.
64. Lipman S, Cohen S, Einav S, Jeejeebhoy F, Mhyre JM, Morrison LJ et al. The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the management of cardiac arrest in pregnancy. Anesth Analg 2014; 118:1003-1016.
65. Choo KJL, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2010; 65:1205-1211.
66. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin North Am 2007; 27:309-326.
67. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007; 62:830-837.
68. Ellis BC, Brown SG. Parenteral antihistamines cause hypotension in anaphylaxis. Emerg Med Australas 2013; 25:92-93.
69. Ebo DG, Fisher MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007; 62:471-487.
70. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin N Am 2006; 26:451-463.